Next, we examined the active GSK3β levels in PBMCs from patients with JDM1 and CDM1 by Western blot analysis using the protocol applied to the analysis of adult-onset DM1 patients. The gene discussed is GSK3B; the disease is myotonic dystrophy type 1.